Sifalimumab, CAS 1006877-41-3

Product Description: Sifalimumab (MEDI-545) is an anti-IFNα monoclonal antibody. Sifalimumab suppresses the abnormal immune activity by binding to multiple interferon-alpha (IFNα) subtypes. Sifalimumab can be used in systemic lupus erythematosus (SLE) research[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]La Maestra S, et al. Brain microglia activation induced by intracranial administration of oligonucleotides and its pharmacological modulation. Drug Deliv Transl Res. 2018 Oct;8(5):1345-1354./[2]Merrill JT, et al. Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study. Ann Rheum Dis. 2011 Nov;70(11):1905-13.

CAS Number: 1006877-41-3

Molecular Weight: N/A

Compound Purity: 98.55

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: IFNAR

• Artikelnummer: MEXHY-P99219-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99219-1
• Green Labware: Nein
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK